The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Agoraphobia Without Panic Disorder — Diagnosis and Treatment

Comprehensive understanding of agoraphobia as an independent diagnostic entity in DSM-5, characterized by fear of multiple agoraphobic situations independent of panic attacks, with evidence-based exposure therapy and pharmacologic management.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Psikiyatri department. Book Appointment →

What is Agoraphobia Without Panic Disorder — Diagnosis and Treatment?

Agoraphobia, derived from Greek 'agora' (marketplace) and 'phobia' (fear), originally described fear of public spaces but has been substantially redefined in DSM-5 as a distinct anxiety disorder. Diagnostic criteria require marked fear or anxiety about two or more of five situations: using public transportation, being in open spaces, being in enclosed places, standing in line or being in a crowd, or being outside of the home alone. The fear must arise from thoughts that escape might be difficult or help might be unavailable in the event of developing panic-like or other incapacitating/embarrassing symptoms.

The DSM-5 separation of agoraphobia from panic disorder reflects research showing that agoraphobia can develop without panic attacks (approximately 25-50% of cases), arising instead from fears of physical incapacitation (falling, vomiting, incontinence) or social embarrassment in situations difficult to escape. This recognition is clinically important as treatment approaches differ: pure agoraphobia without panic emphasizes situational exposure without interoceptive exposure to feared bodily sensations.

Lifetime prevalence is approximately 1-2%, with female predominance and onset typically in adolescence or early adulthood. The disorder shows considerable comorbidity with depression, other anxiety disorders, and substance use disorders, with significant functional impairment from progressive avoidance leading to housebound states in severe cases. Evidence-based treatment centers on cognitive-behavioral therapy with graduated in vivo exposure, where patients systematically confront avoided situations from least to most anxiety-provoking with cognitive restructuring of catastrophic predictions. Pharmacotherapy with SSRIs (sertraline, escitalopram, paroxetine) or SNRIs (venlafaxine) provides effective adjunctive treatment, while benzodiazepines should generally be avoided as long-term agents due to dependence risk and interference with exposure-based learning.

Symptoms

Marked fear or anxiety about using public transportation
Fear of being in open spaces (parking lots, marketplaces, bridges)
Fear of being in enclosed places (shops, theaters, cinemas)
Fear of standing in line or being in a crowd
Fear of being outside of the home alone
Active avoidance, requiring presence of companion, or endurance with intense fear
Significant impairment in occupational, academic, or social functioning

Risk Factors

Female sex (2:1 female predominance)
Onset typically in adolescence or early adulthood (mean age 20-25)
Family history of anxiety disorders or agoraphobia
Behavioral inhibition temperament in childhood
Stressful or traumatic life events as precipitants
Childhood adversity, separation anxiety, or overprotective parenting
Comorbid panic disorder, depression, or other anxiety disorders

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Avoidance of multiple situations interfering with daily life
  • Inability to leave home alone or use public transportation
  • Significant occupational or academic impairment
  • Comorbid depression or anxiety symptoms
  • Substance use as self-medication for anxiety
  • Suicidal ideation related to functional limitations
  • Persistent symptoms despite self-help efforts

Treatment Methods

01
Cognitive-behavioral therapy with graduated in vivo exposure (gold standard)
02
Cognitive restructuring of catastrophic thoughts about feared situations
03
Self-directed exposure homework with hierarchical fear ladder
04
SSRIs (sertraline, escitalopram, paroxetine) for moderate-severe symptoms
05
SNRIs (venlafaxine) as alternative first-line pharmacologic option
06
Brief benzodiazepine use only for severe acute distress, not chronic management
07
Combined CBT and pharmacotherapy for severe or treatment-resistant cases

Which Department to Visit?

You can visit our Psikiyatri department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Psikiyatri Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.